1. Home
  2. SDST vs QTTB Comparison

SDST vs QTTB Comparison

Compare SDST & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc.

SDST

Stardust Power Inc.

HOLD

Current Price

$3.79

Market Cap

44.9M

Sector

Finance

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$3.49

Market Cap

40.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDST
QTTB
Founded
2022
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
40.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SDST
QTTB
Price
$3.79
$3.49
Analyst Decision
Buy
Hold
Analyst Count
2
3
Target Price
$17.00
$7.33
AVG Volume (30 Days)
94.5K
201.6K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$1.35
52 Week High
$37.95
$6.37

Technical Indicators

Market Signals
Indicator
SDST
QTTB
Relative Strength Index (RSI) 55.25 63.81
Support Level $2.98 $3.22
Resistance Level $3.75 $3.77
Average True Range (ATR) 0.28 0.24
MACD 0.07 0.02
Stochastic Oscillator 83.52 72.94

Price Performance

Historical Comparison
SDST
QTTB

About SDST Stardust Power Inc.

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: